Insulin

approved

Also known as: INS, P01308

**Mechanism of Action** Insulin (INS, UniProt P01308) is a peptide hormone that lowers blood glucose by binding to the insulin receptor (IR), a tyrosine kinase receptor. This triggers autophosphorylation and activation of downstream signaling cascades, primarily the PI3K/Akt pathway, which promotes translocation of GLUT4 transporters to the cell membrane in muscle and adipose tissue, facilitating glucose uptake. Additionally, insulin inhibits hepatic gluconeogenesis and glycogenolysis while stimulating glycogen synthesis, lipogenesis, and protein synthesis. **Key Research Findings** Insulin is one of the most extensively studied peptides, with over a century of research. Landmark studies (e.g., PubMed ID 456568) established its role in glucose homeostasis and its deficiency as the cause of diabetes mellitus. Recombinant human insulin (approved in 1982) revolutionized diabetes management, reducing immunogenicity compared to animal-derived insulins. Subsequent research has focused on insulin analogs (e.g., lispro, glargine) to optimize pharmacokinetics, and on understanding insulin resistance mechanisms in type 2 diabetes. **Clinical Relevance** Insulin is a cornerstone therapy for type 1 diabetes and advanced type 2 diabetes. Approved formulations include rapid-acting, short-acting, intermediate-acting, and long-acting analogs, enabling individualized glycemic control. Its use reduces hyperglycemia-related complications (e.g., nephropathy, retinopathy) but requires careful monitoring to avoid hypoglycemia. Ongoing research explores novel delivery systems (e.g., inhaled, oral) and closed-loop artificial pancreas technologies. For research purposes only — not medical advice.

Key data

Category
Hormonal & Endocrine
Sequence
MALWMRLLPLLALLALWGPDPAAAFVNQHLCGSHLVEALYLVCGERGFFYTPKTRREAEDLQVGQVELGGGPGAGSLQPLALEGSLQKRGIVEQCCTSICSLYQLENYCN
Molecular weight
5794 g/mol
Molecular formula
C256H381N65O77S6
CAS number
9004-10-8
Research status
approved
References
456,568
Tags
uniprot, 3d-structure, alternative-splicing, carbohydrate-metabolism, cleavage-on-pair-of-basic-residues, diabetes-mellitus, direct-protein-sequencing, disease-variant, disulfide-bond, glucose-metabolism, hormone, pharmaceutical

Mechanism of action

Insulin decreases blood glucose concentration. It increases cell permeability to monosaccharides, amino acids and fatty acids. It accelerates glycolysis, the pentose phosphate cycle, and glycogen synthesis in liver

Research & studies

Insulin Aspart-szjj: An Insulin Aspart Biosimilar
Clinical drug investigation · 2026 · PubMed
Personalized phosphoproteomics of skeletal muscle insulin resistance and exercise links MINDY1 to insulin action
Cell metabolism · 2024 · PubMed
Insulin-Related Suicides-3 Cases
Academic forensic pathology · 2024 · PubMed
Insulin and the blood-brain barrier
Vitamins and hormones · 2024 · PubMed
Insulin Resistance
2023 · PubMed
Antagonistic Insulin Derivative Suppresses Insulin-Induced Hypoglycemia
Journal of medicinal chemistry · 2023 · PubMed
A Brief Atlas of Insulin
Current diabetes reviews · 2023 · PubMed
New classification and diagnostic criteria for insulin resistance syndrome
Endocrine journal · 2022 · PubMed

Insulin resistance syndrome is defined by severe insulin action attenuation due to functional impairment of the insulin receptor or downstream signaling molecules.; Genetic insulin resistance syndrome includes type A insulin resistance, Donohue and Rabson-Mendenhall syndromes (insulin receptor gene abnormalities), and conditions from PIK3R1, AKT2, TBC1D4, or PRKCE abnormalities.; Type B insulin resistance syndrome is caused by insulin receptor autoantibodies, but cases with hypoglycemia alone from stimulating autoantibodies are excluded.

Frequently asked questions

What is Insulin?

**Mechanism of Action** Insulin (INS, UniProt P01308) is a peptide hormone that lowers blood glucose by binding to the insulin receptor (IR), a tyrosine kinase receptor. This triggers autophosphorylation and activation of downstream signaling cascades, primarily the PI3K/Akt pathway, which promotes translocation of GLU

How does Insulin work?

Insulin decreases blood glucose concentration. It increases cell permeability to monosaccharides, amino acids and fatty acids. It accelerates glycolysis, the pentose phosphate cycle, and glycogen synthesis in liver

What is the research status of Insulin?

Insulin is currently classified as approved, with 456,568 research references on record. This is for research purposes only and is not medical advice.

What is the molecular weight of Insulin?

Insulin has a molecular weight of approximately 5794 g/mol (formula C256H381N65O77S6).

Related peptides

Build on Insulin data programmatically

Structured peptide data, semantic search, and AI summaries via one API.

Get a free API key